Pathological gambling in Parkinson's disease improves on chronic subthalamic nucleus stimulation
- 13 September 2006
- journal article
- clinical trial
- Published by Wiley in Movement Disorders
- Vol. 21 (11) , 1941-1946
- https://doi.org/10.1002/mds.21098
Abstract
Pathological gambling (PG) related to dopaminergic treatment in Parkinson's disease (PD) is part of a spectrum of behavioral disorders called the dopamine dysregulation syndrome (DDS). We describe a series of PD patients with preoperative active PG due to dopaminergic treatment from a total of 598 patients who have undergone surgery for subthalamic nucleus stimulation for disabling motor fluctuations. The patients had systematic open assessment of behavioral symptoms and standardized assessments of motor symptoms, mood, and apathy. Seven patients (6 men, 1 woman; age, 54 ± 9 years; levodopa equivalent dose, 1,390 ± 350 mg/day) had preoperative PG over a mean of 7 years, intolerant to reduction in medication. Six had nonmotor fluctuations and four had other behavioral symptoms consistent with a diagnosis of the DDS. After surgery, motor symptoms improved, allowing for 74% reduction of dopaminergic treatment, below the dosage of gambling onset. In all patients, PG resolved postoperatively after 18 months on average (range, 0–48), although transient worsening occurred in two. Improvement paralleled the time course and degree of reduction in dopaminergic treatment. Nonmotor fluctuations, off period dysphoria, and other symptoms of the DDS improved. Two patients developed persistent apathy. In conclusion, PG and other symptoms of the DDS‐associated dopaminergic treatment improved in our patients following surgery. Dopaminergic dysregulation commonly attributed to pulsatile overstimulation of the limbic dopaminergic system may be subject to desensitization on chronic subthalamic stimulation, which has a relative motor selectivity and allows for decrease in dopaminergic treatment. © 2006 Movement Disorder SocietyKeywords
This publication has 43 references indexed in Scilit:
- Stimulation of the subthalamic nucleus in Parkinson's disease: a 5 year follow upJournal of Neurology, Neurosurgery & Psychiatry, 2005
- Does bilateral stimulation of the subthalamic nucleus aggravate apathy in Parkinson's disease?Journal of Neurology, Neurosurgery & Psychiatry, 2005
- Addiction in Parkinson's disease: Impact of subthalamic nucleus deep brain stimulationMovement Disorders, 2005
- Pathological gambling is linked to reduced activation of the mesolimbic reward systemNature Neuroscience, 2005
- Continuous subcutaneous apomorphine therapy improves dyskinesias in Parkinson's disease: A prospective study using single‐dose challengesMovement Disorders, 2004
- Long term effects of bilateral subthalamic nucleus stimulation on cognitive function, mood, and behaviour in Parkinson's diseaseJournal of Neurology, Neurosurgery & Psychiatry, 2004
- Acute psychotropic effects of bilateral subthalamic nucleus stimulation and levodopa in Parkinson's diseaseMovement Disorders, 2003
- Discrete Coding of Reward Probability and Uncertainty by Dopamine NeuronsScience, 2003
- Behavioural disorders, Parkinson's disease and subthalamic stimulationJournal of Neurology, Neurosurgery & Psychiatry, 2002
- Negative symptoms: the ‘pathology’ of motivation and goal-directed behaviourTrends in Neurosciences, 2000